DIP2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.878000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.912640E-01
Normal-vs-Stage2
4.674600E-01
Normal-vs-Stage3
1.005230E-01
Normal-vs-Stage4
5.218800E-01
Stage1-vs-Stage2
3.978800E-01
Stage1-vs-Stage3
1.148790E-01
Stage1-vs-Stage4
4.973200E-01
Stage2-vs-Stage3
1.499190E-01
Stage2-vs-Stage4
9.162000E-01
Stage3-vs-Stage4
1.200360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.032600E-01
Normal-vs-AfricanAmerican
9.462200E-01
Normal-vs-Asian
2.689000E-01
Caucasian-vs-AfricanAmerican
5.543600E-01
Caucasian-vs-Asian
3.286000E-01
AfricanAmerican-vs-Asian
2.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.870000E-01
Normal-vs-Female
4.578200E-01
Male-vs-Female
4.050800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.284000E-01
Normal-vs-Age(41-60Yrs)
9.381800E-01
Normal-vs-Age(61-80Yrs)
4.768600E-01
Normal-vs-Age(81-100Yrs)
3.243800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.146000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.460200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.057800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.954330E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.234840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.616200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.052800E-01
Normal-vs-Daily Drinker
1.239220E-01
Normal-vs-Weekly Drinker
1.679600E-01
Normal-vs-Occasional Drinker
9.695200E-01
Normal-vs-Social Drinker
6.009400E-01
Non Drinker-vs-Daily Drinker
5.537000E-01
Non Drinker-vs-Weekly Drinker
4.927800E-01
Non Drinker-vs-Occasional Drinker
7.292000E-02
Non Drinker-vs-Social Drinker
2.444400E-01
Daily Drinker-vs-Weekly Drinker
8.471600E-01
Daily Drinker-vs-Occasional Drinker
3.430300E-02
Daily Drinker-vs-Social Drinker
1.178850E-01
Weekly Drinker-vs-Occasional Drinker
5.028300E-02
Weekly Drinker-vs-Social Drinker
1.490430E-01
Occasional Drinker-vs-Social Drinker
4.644200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.793210E-01
Normal-vs-Grade 2
3.284100E-02
Normal-vs-Grade 3
4.817000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.259600E-01
Grade 1-vs-Grade 3
3.942400E-01
Grade 1-vs-Grade 4
1.793210E-01
Grade 2-vs-Grade 3
4.059600E-01
Grade 2-vs-Grade 4
3.284100E-02
Grade 3-vs-Grade 4
4.817000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.566570E-01
Normal-vs-NonDiabetic
5.916400E-01
Diabetic-vs-NonDiabetic
1.752370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.374200E-01
Normal-vs-NoPancreatitis
5.548800E-01
Pancreatitis-vs-NoPancreatitis
5.304400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.619400E-01
Normal-vs-N1
4.944800E-01
N0-vs-N1
6.276000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.513200E-01
Normal-vs-TP53-NonMutant
8.863000E-01
TP53-Mutant-vs-TP53-NonMutant
9.966200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
